T11, AT3, PyMT-M, 2208L GEMM tumors treated with H3B-8800

ABSTRACT: The objective is to identify splicing and expression changes that occur after spliceosome inhibition in triple-negative breast cancer using immune competent GEMM tumors.

ORGANISM(S): Mus musculus

PROVIDER: GSE163181 | GEO | 2020/12/17

REPOSITORIES: GEO